Technical Analysis for SBFM - Sunshine Biopharma Inc.

Grade Last Price % Change Price Change
F 2.13 -2.30% -0.05
SBFM closed down 4.39 percent on Wednesday, November 20, 2024, on 27 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish -2.30%
New Downtrend Bearish -2.30%
Lower Bollinger Band Walk Weakness -2.30%
New 52 Week Low Weakness -2.30%
Outside Day Range Expansion -2.30%
Wide Bands Range Expansion -2.30%
Below Lower BB Weakness -2.30%
Down 3 Days in a Row Weakness -2.30%
Down 4 Days in a Row Weakness -2.30%
Lower Bollinger Band Touch Weakness -2.30%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 3 hours ago
Fell Below Previous Day's Low about 7 hours ago
Down 2 % about 7 hours ago
Down 1% about 7 hours ago
Rose Above Lower Bollinger Band about 7 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sunshine Biopharma Inc. Description

Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also provides generic prescription drugs for the treatment of breast cancer, prostate cancer, and benign prostatic hyperplasia; and Essential 9, a dietary supplement tablet. Sunshine Biopharma, Inc. has a license agreement with the University of Georgia to advance the development of two anti-coronavirus compounds in parallel with its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. was founded in 2006 and is headquartered in Pointe-Claire, Canada.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Cancer Pharmaceutical Breast Cancer Lymphoma Prostate Cancer Dietary Supplement Treatment Of Breast Cancer Pancreatic Cancer Small Cell Lung Cancer Leukemia Benign Prostatic Hyperplasia Hyperplasia Histopathology Prostate

Is SBFM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 634.0
52 Week Low 2.18
Average Volume 192,865
200-Day Moving Average 44.34
50-Day Moving Average 2.89
20-Day Moving Average 2.68
10-Day Moving Average 2.49
Average True Range 0.17
RSI (14) 21.26
ADX 25.94
+DI 7.71
-DI 26.36
Chandelier Exit (Long, 3 ATRs) 2.68
Chandelier Exit (Short, 3 ATRs) 2.69
Upper Bollinger Bands 3.17
Lower Bollinger Band 2.19
Percent B (%b) -0.01
BandWidth 36.52
MACD Line -0.19
MACD Signal Line -0.14
MACD Histogram -0.0497
Fundamentals Value
Market Cap 61.09 Million
Num Shares 28 Million
EPS -1.63
Price-to-Earnings (P/E) Ratio -1.34
Price-to-Sales 0.26
Price-to-Book 0.29
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.41
Resistance 3 (R3) 2.44 2.39 2.38
Resistance 2 (R2) 2.39 2.33 2.38 2.36
Resistance 1 (R1) 2.28 2.29 2.26 2.26 2.35
Pivot Point 2.23 2.23 2.22 2.22 2.23
Support 1 (S1) 2.13 2.17 2.10 2.10 2.01
Support 2 (S2) 2.08 2.14 2.06 2.00
Support 3 (S3) 1.97 2.08 1.99
Support 4 (S4) 1.95